Dendritic cells in cardiovascular diseases: epiphenomenon, contributor, or therapeutic opportunity

Circulation. 2013 Dec 17;128(24):2603-13. doi: 10.1161/CIRCULATIONAHA.113.003364.

Authors

Anette Christ¹, Lieve Temmerman, Bart Legein, Mat J A P Daemen, Erik A L Biessen

Affiliation

¹ Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, the Netherlands (A.C., L.T., B.L., E.A.L.B.); Department of Cell Biology, Institute for Biomedical Engineering, Aachen University Hospital, Aachen, Germany (A.C.); and Department of Pathology, Amsterdam Medical Center, Amsterdam, The Netherlands (M.J.A.P.D.).

PMID: 24344059
DOI: 10.1161/CIRCULATIONAHA.113.003364

No abstract available

Keywords: antigens; cardiovascular diseases; dendritic cells; immune system; immune system phenomena; immunosuppression; therapeutics.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Animals
Cardiovascular Diseases / epidemiology
Cardiovascular Diseases / physiopathology*
Cardiovascular Diseases / therapy*
Dendritic Cells / classification
Dendritic Cells / physiology*
Disease Models, Animal
Humans
Immune System / physiology
Immunotherapy
Mice
Risk Factors